United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 6 minute read Technology Industry News Amphenol (NYSE: APH) goes all-in on AI hardware with CCS deal and $7bn sales target for Q1 2026 Amphenol targets up to $7B in Q1 2026 sales, fueled by the CommScope CCS acquisition and surging demand for AI infrastructure connectivity systems. byVenkateshJanuary 29, 2026